Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow Us: 

Search by Ticker, Keyword or CUSIP       
 
 
First Trust Capital Strength ETF (FTCS)
Investment Objective/Strategy - The First Trust Capital Strength ETF seeks investment results that correspond generally to the price and yield (before the fund's fees and expenses) of an equity index called The Capital Strength IndexSM.
There can be no assurance that the Fund's investment objectives will be achieved.
  • A security must be a common stock or REIT that is a member of the NASDAQ US Benchmark Index. The largest 500 securities by float-adjusted market capitalization with a minimum three-month average daily dollar trading volume of $5 million are selected. Multiple share classes of the same issuer are excluded.
  • To be eligible for inclusion in the Index, companies must have:
    • at least $1 billion in cash or short term investments.
    • a long term debt to market cap ratio less than 30%.
    • a return on equity greater than 15%.
  • Eligible companies are then ranked by a combined short-term (3 months) and long-term (12 months) realized volatility.
  • The 50 companies with the lowest combined volatility score are selected for inclusion in the Index.
  • A maximum weight of 30% in any one Industry Classification Benchmark industry is allowed. If an industry has a weight greater than 30%, the highest ranking security by volatility will be removed and replaced with the next eligible security from a different industry. This process is repeated until no industry has a weight greater than 30%.
  • The Index stocks are equally weighted initially and on each rebalancing effective date. The index is reconstituted and rebalanced on a quarterly basis.
Fund Overview
TickerFTCS
Fund TypeLarge Cap Core
Investment AdvisorFirst Trust Advisors L.P.
Investor Servicing AgentBank of New York Mellon Corp
CUSIP33733E104
ISINUS33733E1047
Intraday NAVFTCSIV
Fiscal Year-End12/31
ExchangeNasdaq
Inception7/6/2006
Inception Price$20.00
Inception NAV$20.00
Rebalance FrequencyQuarterly
Gross Expense Ratio*0.55%
Net Expense Ratio*0.55%
* As of 5/2/2022
Expenses are capped contractually at 0.65% per year, at least until April 30, 2023. Please see the Fees and Expenses of the Fund section in the fund’s prospectus for more details.
Current Fund Data (as of 5/20/2022)
Closing NAV1$71.09
Closing Market Price2$71.08
Bid/Ask Midpoint$71.08
Bid/Ask Discount0.01%
30-Day Median Bid/Ask Spread30.04%
Total Net Assets$7,937,053,172
Outstanding Shares111,650,002
Daily Volume510,208
Average 30-Day Daily Volume438,578
Closing Market Price 52-Week High/Low$84.75 / $70.77
Closing NAV 52-Week High/Low$84.72 / $70.76
Number of Holdings (excluding cash)50
Top Holdings (as of 5/20/2022)*
Holding Percent
Expeditors International of Washington, Inc. 2.37%
Merck & Co., Inc. 2.34%
Illinois Tool Works Inc. 2.23%
Hologic, Inc. 2.21%
The Progressive Corporation 2.15%
Johnson & Johnson 2.14%
Bristol-Myers Squibb Company 2.13%
3M Company 2.12%
Amgen Inc. 2.12%
Thermo Fisher Scientific Inc. 2.12%

* Excluding cash.  Holdings are subject to change.

NAV History (Since Inception)
Past performance is not indicative of future results.
Overall Morningstar RatingTM (as of 4/30/2022)4

Among 1,212 funds in the Large Blend category. This fund was rated 3 stars/1,212 funds (3 years), 3 stars/1,104 funds (5 years), 4 stars/808 funds (10 years) based on risk adjusted returns.
Distribution Information
Dividend per Share Amt (as of 5/22/2022)5$0.1956
30-Day SEC Yield (as of 4/29/2022)61.17%
Unsubsidized 30-Day SEC Yield (as of 4/29/2022)71.17%
12-Month Distribution Rate (as of 4/29/2022)81.14%
Index Yield (as of 4/29/2022)91.72%
Fund Characteristics (as of 4/29/2022)11
Maximum Market Cap.$713,407
Median Market Cap.$81,615
Minimum Market Cap.$16,584
Price/Earnings18.58
Price/Book4.53
Price/Cash Flow15.26
Price/Sales1.90
Bid/Ask Premium/Discount (as of 5/20/2022)
  2021 Q1 2022 Q2 2022 Q3 2022
Days Traded at Premium 186 37 26 ---
Days Traded at Discount 66 25 9 ---
Top Sector Exposure (as of 5/20/2022)
Health Care 31.05%
Industrials 24.41%
Financials 21.32%
Consumer Staples 12.18%
Technology 3.94%
Consumer Discretionary 3.19%
Basic Materials 2.09%
Telecommunications